
Tempus AI’s £375M Ambry Deal: A Leap Towards Genomic Dominance
In the dynamic domain of genomics and precision medicine, the recent announcement by Tempus AI to acquire Ambry Genetics for a staggering $600 million has captured significant attention. To gain insight into this pivotal development, […]